Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yisaipu plus methotrexate in active rheumatoid arthritis: cytokine and immune cell changes vs clinical response
ChiCTR2200055292Phase 4Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2022
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etanercept in rheumatoid arthritis (RA), sponsored by Peking University People's Hospital. Primary endpoints: ESR, C-reactive protein and 2 more. Started Jan 2022; status: recruiting.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR2200055292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055292.